The burden of cervical cancer in China: synthesis of the evidence.
about
The impact of HPV vaccination delays in China: lessons from HBV control programs.Synergistic effects of a novel lipid-soluble extract from Pinellia pedatisecta Schott and cisplatin on human cervical carcinoma cell lines through the regulation of DNA damage response signaling pathwayMicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.Synergistic cytotoxic effects of a combined treatment of a Pinellia pedatisecta lipid-soluble extract and cisplatin on human cervical carcinoma in vivo.Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland ChinaEvaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling studyCyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing studyImmunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years.Cancer burden in China and the role of the cancer registries.Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Lower cost strategies for triage of human papillomavirus DNA-positive women.Clinical application of DNA ploidy to cervical cancer screening: A review.Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trialAldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results.Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive CarcinomaEstimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studiesLow folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis.Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathwayHuman papillomavirus genital infections among men, China, 2007-2009Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, ChinaAssociation between folate status and cervical intraepithelial neoplasia1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione Induces G1 Cell Cycle Arrest and Autophagy in HeLa Cervical Cancer Cells.Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study.Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus-infected cervical cancer cells.Health Disparity and Cancer Health Disparity in China.Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China.Distribution of various types of low-risk human papillomavirus according to cervical cytology and histology in northern Chinese women.Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China.Incidence of Cancer in Shenzhen, Guangdong Province during 2001-2015: A Retrospective Population-Based Study.The Incidence and Mortality of Cervical Cancer in Ningbo during 2006–2014, China.Subhaplogroup D4b1 enhances the risk of cervical cancer initiation: A case-control study in southern China.HMGB1 overexpression correlates with poor prognosis in early-stage squamous cervical cancer.TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.Trends in geographical disparities for cervical cancer mortality in China from 1973 to 2013: a subnational spatio-temporal study.
P2860
Q33586562-558736E8-DEBD-4636-B274-CD4E1A6807AEQ33597926-1618638F-CDFA-439D-AF73-DE8E9360F263Q33628432-2ADD6C37-9655-496E-89DA-4DCC754744A2Q33735091-24F05850-480A-448B-B3D7-72A882220FC1Q33750771-B9D0E95E-7288-44E9-8F71-C627315AD83AQ33853760-910E2DE1-BA38-4339-BAF6-A45E9D92F491Q33916649-F937C241-FACB-4ADF-AD03-43FECE04BB35Q33930993-B97AC759-EDE4-4017-A690-B5724FC7CBA0Q34029095-33F4222F-BD02-4E3A-B6BA-6A9854BBF2BFQ34280370-9DBAE56B-FF3A-49EA-979D-A9752A7FBB1BQ34291136-8D0E6EEB-E1A6-434E-9AB1-BF68C89863D6Q34367497-E5401505-6E5A-4CD2-8D76-376D7EDF611AQ34434281-E580D713-F640-4F5C-9F6D-21F0E025CF35Q34516596-EBD27B5D-A878-4637-80A9-2EDC2B6AA74CQ34657755-4EEF65BC-9B0D-4D75-B6FA-3FEDE7C8EDE6Q34776205-2BD97315-2DDF-4140-B6B3-D7DD2C8D7FC2Q35168501-941AEF43-003B-49C5-8F77-0FB5B1126A70Q35568812-B7FC1BEB-7E00-4020-9863-7F70B19D8A4CQ35685738-3C6FCC4B-96B8-4CA3-866F-2861BB8CD7DCQ36183172-1EC49CAC-0D5A-4B3F-85A9-9A279B54659FQ36213568-C46F1345-836F-456B-9CA5-73FE82EB9272Q36954647-167497FC-CBBD-410F-ADE5-2E935A6DD356Q36962445-42C452C7-A3F7-4B6E-B7E2-069248B1B7D8Q37020451-16D59499-AE7A-470F-9009-9F2D8F91BF30Q37064730-6645823A-C30F-4986-BD50-C2F7BE44C864Q37085137-A77FFFC4-4ED5-49EC-9F24-29B7BA3916DFQ37210035-E886EB77-F4D8-4522-A97F-4D007BEB205BQ37247186-92468A82-21C8-4AF7-9E24-04CD750E251FQ37257474-7403C431-7AAD-4F5F-B5F1-19DF8DAE66A3Q37406428-AF7069EA-E649-4C71-912C-5C21B5564EE4Q37559429-B10B3CB4-E13E-4C50-AA11-920D4DFADF45Q40841456-81A70F02-399B-40A1-95A4-6C6D27B81195Q42220821-DD3515DB-DFD2-4904-A821-6730CC91F154Q42245593-491B38FA-8D07-4DC4-A903-FFEB0234FBF6Q43458945-7ACDCCC2-D25F-4D5C-B4F8-9D3221C34B7BQ47104647-A56FCB20-AC7E-4FB9-937D-DB029CB189D2Q47886390-92DC49BE-19FC-408D-A133-0D8D5E2C0605Q48171241-891CC013-97C8-4F67-AADD-BD04093A81A1Q49180877-A88955E1-006A-4F84-B35E-4B28A2AE702CQ49194033-597E6051-5B24-4323-8F3F-816D2E1B6F07
P2860
The burden of cervical cancer in China: synthesis of the evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The burden of cervical cancer in China: synthesis of the evidence.
@en
The burden of cervical cancer in China: synthesis of the evidence.
@nl
type
label
The burden of cervical cancer in China: synthesis of the evidence.
@en
The burden of cervical cancer in China: synthesis of the evidence.
@nl
prefLabel
The burden of cervical cancer in China: synthesis of the evidence.
@en
The burden of cervical cancer in China: synthesis of the evidence.
@nl
P2860
P356
P1476
The burden of cervical cancer in China: synthesis of the evidence.
@en
P2093
Ju-Fang Shi
Karen Canfell
P2860
P304
P356
10.1002/IJC.26042
P577
2011-06-10T00:00:00Z